Literature DB >> 1155478

Diabetic glomerulosclerosis without glucose intolerance.

D A Nash, P W Rogers, P C Langlinais, S M Bunn.   

Abstract

The pathophysiology of the microangiopathy of diabetes mellitus is poorly understood, and the relevance of carbohydrate intolerance remains uncertain. Four patients are presented with renal abnormalities suggestive of diffuse diabetic glomeruloscierosis. These patients have no evidence of carbohydrate intolerance by standard clinical technics. A familial incidence of diabetes mellitus and delayed insulin response to an oral glucose load support a classification of prediabetes or suspected diabetes mellitus for these patients. Early intercapillary nodule formation was seen in only two of the four patients. In the absence of this infrequent pathognomonic finding, an alternate approach to the diagnosis of diabetic glomerulosclerosis is suggested. Diffuse glomerular capillary basement membrane thickening, consistently present with diabetic glomerulosclerosis, is demonstrated by measurements utilizing the latex microsphere technic. The mean glomerular capillary basement membrane thickness of these patients was 4,403 A, compared with the control value of 3.098 A (P less than 0.001). Other pathologic findings suggestive of diabetic nephropathy include efferent arteriolosclerosis and linear immunofluorescence without electron dense deposits or inflammation. Skeletal muscle capillary basement membranes of all four patients also demonstrated significant thickening. The mean value for the patients was 1,510 A, as compared with a control value of 961 A (P less than 0.001). The importance of this muscle capillary basement membrane thickening to the diagnosis of diabetic microangiopathy is discussed. The pathologic alterations in the renal biopsy specimens and the demonstration of muscle capillary basement membrane thickening strongly suggest that diabetic glomerulosclerosis may occur in the absence of overt clinical carbohydrate intolerance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155478     DOI: 10.1016/0002-9343(75)90353-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases.

Authors:  Jun Wu; Shengqiang Yu; Vickram Tejwani; Michael Mao; Angela K Muriithi; Chaoyang Ye; Xuezhi Zhao; Hongchen Gu; Changlin Mei; Qi Qian
Journal:  Clin Exp Nephrol       Date:  2014-01-10       Impact factor: 2.801

2.  A case of idiopathic nodular glomerulosclerosis with fibrin caps.

Authors:  Chiharu Kinoshita; Yoshimoto Inoue; Yoko Kanda; Chiaki Kanda
Journal:  Clin Exp Nephrol       Date:  2011-08-17       Impact factor: 2.801

Review 3.  Drug-induced glomerular disease: direct cellular injury.

Authors:  Glen S Markowitz; Andrew S Bomback; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

4.  Nodular mesangial glomerulosclerosis in patients without manifest diabetes mellitus.

Authors:  R Jensen; V S Larsen
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

5.  Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.

Authors:  G Pugliese; R G Tilton; A Speedy; K Chang; E Santarelli; M A Province; D Eades; W R Sherman; J R Williamson
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

6.  Uremia in diabetics: the prognosis improves.

Authors:  E A Friedman; M M Beyer
Journal:  Klin Wochenschr       Date:  1980-10-01

Review 7.  The case for control in diabetes mellitus.

Authors:  M B Davidson
Journal:  West J Med       Date:  1978-09

8.  [Morphologic-clinical correlation in different forms of diabetic glomerulosclerosis].

Authors:  H Wehner; S Stiefel
Journal:  Klin Wochenschr       Date:  1982-08

9.  Nodular glomerulosclerosis in a patient with cystic fibrosis, but not diabetes mellitus: A paediatric case.

Authors:  A D Lalayiannis; C Thompson; R Malcomson; D V Milford
Journal:  Respir Med Case Rep       Date:  2016-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.